Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Mustafa Daghistani"'
Autor:
Wasil Jastaniah, Naglla Elimam, Khalid Abdalla, Aeshah A. AlAzmi, Aml M. Elgaml, Ahmad Alkassar, Mustafa Daghistani, Sami Felimban
Publikováno v:
Experimental Hematology & Oncology, Vol 7, Iss 1, Pp 1-15 (2018)
Abstract Background Refinement of risk-based treatment stratification by minimal residual disease (MRD) at different time points has improved outcomes of childhood acute lymphoblastic leukemia (ALL). In this prospective study we evaluated effects of
Externí odkaz:
https://doaj.org/article/5360adfac9934965b4bd6265988d5745
Autor:
Ayman M Saleh, Mahmoud A. Al-Qudah, Amre Nasr, Sayed A. Rizvi, Anwar Borai, Mustafa Daghistani
Publikováno v:
Cellular Physiology and Biochemistry, Vol 42, Iss 5, Pp 2043-2065 (2017)
Background/Aims: In our quest for new natural anticancer agents, we studied the cytotoxicity of the essential oils extracted from flowers and leaves of Pallines spinosa. Methods: The essential oils were extracted by hydrodistillation and solid phase
Externí odkaz:
https://doaj.org/article/aba2c6bc6dc649fd8faf1339b011b079
Autor:
Ashraf Warsi, Sameer Alamoudi, Anas K. Alsuraihi, Mohammed Althobaiti, Mustafa Daghistani, Kawlah Samarin, Mariah O. Alahmadi, Reema Ghazi Abuyabis, Raha A. Bogari, Sarah AhmadZaki Filimban
Publikováno v:
American Journal of Case Reports. 24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cfbbe25882072659af48007e58008c3
https://doi.org/10.12659/ajcr.938488
https://doi.org/10.12659/ajcr.938488
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4108e4d2fb1715de3bb70af73eadf530
https://doi.org/10.7759/cureus.24561
https://doi.org/10.7759/cureus.24561
Autor:
Mohammad H. Al-Qahtani, Bader Shirah, Muhammad Imran Naseer, Angham Abdulrahman Abdulkareem, Hussein Algahtani, Mustafa Daghistani
Publikováno v:
Neuropediatrics. 52:150-152
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47819ded4a1e6730dd76639e6afcc694
https://doi.org/10.1055/s-0040-1712528
https://doi.org/10.1055/s-0040-1712528
Autor:
Amre Nasr, Ayman M. Saleh, Mahmoud A. Al-Qudah, Sayed A Rizvi, Anwar Borai, Mustafa Daghistani
Publikováno v:
Cellular Physiology and Biochemistry, Vol 42, Iss 5, Pp 2043-2065 (2017)
Background/Aims: In our quest for new natural anticancer agents, we studied the cytotoxicity of the essential oils extracted from flowers and leaves of Pallines spinosa. Methods: The essential oils were extracted by hydrodistillation and solid phase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cca230d259eb0aa52913686c5d31249a
http://www.karger.com/Article/FullText/479900
http://www.karger.com/Article/FullText/479900
Autor:
Sami Felimban, Aeshah AlAzmi, Mustafa Daghistani, Ahmad Alkassar, Naglla Elimam, Wasil Jastaniah, Aml M. Elgaml, Khalid Abdalla
Publikováno v:
Experimental Hematology & Oncology
Experimental Hematology & Oncology, Vol 7, Iss 1, Pp 1-15 (2018)
Experimental Hematology & Oncology, Vol 7, Iss 1, Pp 1-15 (2018)
Background Refinement of risk-based treatment stratification by minimal residual disease (MRD) at different time points has improved outcomes of childhood acute lymphoblastic leukemia (ALL). In this prospective study we evaluated effects of such stra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4928d61c0baabb662d70b0129696dfb0
https://doi.org/10.1186/s40164-018-0121-x
https://doi.org/10.1186/s40164-018-0121-x
Autor:
Jacob Grinfeld, David Marin, Mustafa Daghistani, Richard E. Clark, Mary Alikian, Jane F. Apperley, Gareth Gerrard, Letizia Foroni, Juan M. Alonso-Dominguez, Alistair Reid, Corinne Hedgley, Stephen J. O'Brien
Publikováno v:
American Journal of Hematology. 90:20-26
The tyrosine kinase inhibitor (TKI) imatinib has revolutionized the management of chronic myeloid leukaemia (CML). However, around 25% of patients fail to sustain an adequate response. We sought to identify gene-expression biomarkers that could be us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c828b7af10b38db932539d9ea846e6c
https://doi.org/10.1002/ajh.23857
https://doi.org/10.1002/ajh.23857
Autor:
Richard E. Clark, Jane F. Apperley, Alistair Reid, Philippa C. May, Mustafa Daghistani, Letizia Foroni, David Marin, Lihui Wang, Jamshid S. Khorashad, Gareth Gerrard, Christos Paliompeis, Dragana Milojkovic, John M. Goldman, Valeria A. S. De Melo
Publikováno v:
Blood. 116:6014-6017
Activation of the EVI-1 oncogene has been reported in acute myeloid leukemia, chronic myeloid leukemia (CML) in blast crisis, and less commonly, in chronic-phase CML patients. We screened an unselected cohort of 75 chronic-phase CML patients who had
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccf9425cebc9ce457e39ff3d0411dae1
https://doi.org/10.1182/blood-2010-01-264234
https://doi.org/10.1182/blood-2010-01-264234
Autor:
Juan M, Alonso-Dominguez, Jacob, Grinfeld, Mary, Alikian, David, Marin, Alistair, Reid, Mustafa, Daghistani, Corinne, Hedgley, Stephen, O'Brien, Richard E, Clark, Jane, Apperley, Letizia, Foroni, Gareth, Gerrard
Publikováno v:
American journal of hematology. 90(1)
The tyrosine kinase inhibitor (TKI) imatinib has revolutionized the management of chronic myeloid leukaemia (CML). However, around 25% of patients fail to sustain an adequate response. We sought to identify gene-expression biomarkers that could be us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7ae50ffb9d9fb13b464388a7e555bb7f
https://pubmed.ncbi.nlm.nih.gov/25250944
https://pubmed.ncbi.nlm.nih.gov/25250944